HASBROUCK HEIGHTS, N.J., Aug. 12, 2011 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today its financial results for the second quarter of 2011, prepared in accordance with International Financial Reporting Standards. Nymox reported a net loss of $1,948,132, or $0.06 per share for the quarter and $6,379,223, or $0.20 per share for the six months ending June 30, 2011, compared to $1,646,586, or $0.05 per share for the quarter and $2,829,938 or $0.09 per share for the six months ending June 30, 2010. Net losses include stock-based compensation charges of $3,666,158 in the six-month period ended June 30, 2011 and $255,055 in the comparative period in 2010. The increase in net losses is attributable to higher stock-based compensation charges compared to 2010.
